No Data
No Data
11 Oversold Biotech Stocks To Buy Right Now
Aurinia Pharmaceuticals (NASDAQ:AUPH Shareholders Incur Further Losses as Stock Declines 6.1% This Week, Taking Three-year Losses to 61%
Investing in stocks inevitably means buying into some companies that perform poorly. But long term Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) shareholders have had a particularly rough ride in the la
We're Not Worried About Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn
Aurinia Pharmaceuticals Insider Sold Shares Worth $323,372, According to a Recent SEC Filing
Stephen P. Robertson, Executive Vice President, General Counsel, on March 06, 2024, sold 57,745 shares in Aurinia Pharmaceuticals (AUPH) for $323,372. Following the Form 4 filing with the SEC, Roberts
Express News | HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $13 Price Target
Aurinia Pharmaceuticals: Strong Buy Rating Amidst Share Repurchase and Promising LUPKYNIS Prospects
No Data